申请人:Baettig Urs
公开号:US20080312322A1
公开(公告)日:2008-12-18
A compound of formula (I); in free or pharmaceutically acceptable salt form, where R
1
, R
2
, R
3
, R
4
, R
5
, m, n, w, X, Y and Q have the meanings as indicated in the specification, are useful for treating conditions mediated by the CRTh
2
receptor, especially inflammatory or obstructive airways diseases.
化合物公式为(I)的复合物;以自由形式或药学上可接受的盐形式存在,其中R1、R2、R3、R4、R5、m、n、w、X、Y和Q的含义如规范所示,可用于治疗由CRTh2受体介导的疾病,特别是炎症性或阻塞性呼吸道疾病。